This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
H Akarsu , K Iwatsuki-Horimoto , T Noda , E Kawakami , H Katsura , F Baudin , T Horimoto and Y Kawaoka (2011). Structure-based design of NS2 mutants for attenuated influenza A virus vaccines. Virus Research 155: 240–248.
DJ Alexander and IH Brown (2000). Recent zoonoses caused by influenza A viruses. Revue Scientifique et Technique 19: 197–225.
S Babiuk , A Masic , J Graham , J Neufeld , M van der Loop , J Copps , Y Berhane , J Pasick , A Potter , LA Babiuk , H Weingartl and Y Zhou (2011). An elastase-dependent attenuated heterologous swine influenza virus protects against pandemic H1N1 2009 influenza challenge in swine. Vaccine 29: 3118–3123.
WE Backstrom , S Abdurahman , A Tranell , S Lindstrom , S Tingsborg and S Schwartz (2011). Inefficient splicing of segment 7 and 8 mRNAs is an inherent property of influenza virus A/Brevig Mission/1918/1 (H1N1) that causes elevated expression of NS1 protein. Virology 422: 46–58.
D Baltimore , AS Huang and M Stampfer (1970). Ribonucleic acid synthesis of vesicular stomatitis virus, II. An RNA polymerase in the virion. Proceedings of the National Academy of Sciences of the United States of America 66: 572–576.
B Bosworth , MM Erdman , DL Stine , I Harris , C Irwin , M Jens , A Loynachan , K Kamrud and DL Harris (2010). Replicon particle vaccine protects swine against influenza. Comparative Immunology, Microbiology and Infectious Diseases 33: e99–e103.
RB Belshe (2004). Current status of live attenuated influenza virus vaccine in the US. Virus Research 103: 177–185.
NM Bouvier and P Palese (2008). The biology of influenza viruses. Vaccine 26 (Suppl 4): D49–53.
DR Braucher , JN Henningson , CL Loving , AL Vincent , E Kim , J Steitz , AA Gambotto and ME Kehrli Jr, (2012). Intranasal vaccination with replication-defective adenovirus type 5 encoding influenza virus hemagglutinin elicits protective immunity to homologous challenge and partial protection to heterologous challenge in pigs. Clinical and Vaccine Immunology 19: 1722–1729.
RA Bright , DM Carter , S Daniluk , FR Toapanta , A Ahmad , V Gavrilov , M Massare , P Pushko , N Mytle , T Rowe , G Smith and TM Ross (2007). Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 25: 3871–3878.
IH Brown (2000). The epidemiology and evolution of influenza viruses in pigs. Veterinary Microbiology 74: 29–46.
IH Brown , PA Harris , JW McCauley and DJ Alexander (1998). Multiple genetic reassortment of avian and human influenza A viruses in European pigs, resulting in the emergence of an H1N2 virus of novel genotype. Journal of General Virology 79: 2947–2955.
W Chan , H Zhou , G Kemble and H Jin (2008). The cold adapted and temperature sensitive influenza A/Ann Arbor/6/60 virus, the master donor virus for live attenuated influenza vaccines, has multiple defects in replication at the restrictive temperature. Virology 380: 304–311.
YK Choi , SM Goyal , MW Farnham and HS Joo (2002). Phylogenetic analysis of H1N2 isolates of influenza A virus from pigs in the United States. Virus Research 87: 173–179.
KK Conzelmann (1998). Nonsegmented negative-strand RNA viruses: genetics and manipulation of viral genomes. Annual Review of Genetics 32: 123–162.
MM Cox and JR Hollister (2009). FluBlok, a next generation influenza vaccine manufactured in insect cells. Biologicals: Journal of the International Association of Biological Standardization 37: 182–189.
RJ Cox , KA Brokstad and P Ogra (2004). Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scandinavian Journal of Immunology 59: 1–15.
MA D'Aoust , PO Lavoie , MM Couture , S Trepanier , JM Guay , M Dargis , S Mongrand , N Landry , BJ Ward and LP Vezina (2008). Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. Plant Biotechnology Journal 6: 930–940.
K Dhama , M Mahendran , PK Gupta and A Rai (2008). DNA vaccines and their applications in veterinary practice: current perspectives. Veterinary Research Communications 32: 341–356.
E Domingo , E Baranowski , CM Ruiz-Jarabo , AM Martin-Hernandez , JC Saiz and C Escarmis (1998). Quasispecies structure and persistence of RNA viruses. Emerging Infectious Diseases 4: 521–527.
J Ellis , E Clark , D Haines , K West , S Krakowka , S Kennedy and GM Allan (2004). Porcine circovirus-2 and concurrent infections in the field. Veterinary Microbiology 98: 159–163.
MM Erdman , KI Kamrud , DL Harris and J Smith (2010). Alphavirus replicon particle vaccines developed for use in humans induce high levels of antibodies to influenza virus hemagglutinin in swine: proof of concept. Vaccine 28: 594–596.
C Fablet , C Marois-Crehan , G Simon , B Grasland , A Jestin , M Kobisch , F Madec and N Rose (2012). Infectious agents associated with respiratory diseases in 125 farrow-to-finish pig herds: a cross-sectional study. Veterinary Microbiology 157: 152–163.
G Gabriel , H Garn , M Wegmann , H Renz , A Herwig , HD Klenk and J Stech (2008). The potential of a protease activation mutant of a highly pathogenic avian influenza virus for a pandemic live vaccine. Vaccine 26: 956–965.
RJ Garten , CT Davis , CA Russell , B Shu , S Lindstrom , A Balish , WM Sessions , X Xu , E Skepner , V Deyde , M Okomo-Adhiambo , L Gubareva , J Barnes , CB Smith , SL Emery , MJ Hillman , P Rivailler , J Smagala , MD Graaf , DF Burke , RAM Fouchier , C Pappas , CM Alpuche-Aranda , H López-Gatell , H Olivera , I López , CA Myers , D Faix , PJ Blair , C Yu , KM Keene , PD Dotson Jr., D Boxrud , AR Sambol , SH Abid , KS George , T Bannerman , AL Moore , DJ Stringer , P Blevins , GJ Demmler-Harrison , M Ginsberg , P Kriner , S Waterman , S Smole , HF Guevara , EA Belongia , PA Clark , ST Beatrice , R Donis , J Katz , L Finelli , CB Bridges , M Shaw , DB Jernigan , TM Uyeki , DJ Smith , AI Klimov and NJ Cox . (2009). Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197–201.
PC Gauger , AL Vincent , CL Loving , KM Lager , BH Janke , ME Kehrli and JA Roth (2011). Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (delta-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus. Vaccine 29: 2712–2719.
JP Gorres , KM Lager , WP Kong , M Royals , JP Todd , AL Vincent , CJ Wei , CL Loving , EL Zanella , B Janke , ME Kehrli , GJ Nabel and SS Rao (2011). DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs. Clinical and Vaccine Immunology 18: 1987–1995.
U Grienke , M Schmidtke , S von Grafenstein , J Kirchmair , KR Liedl and JM Rollinger (2012). Influenza neuraminidase: a druggable target for natural products. Natural Product Reports 29: 11–36.
BG Hale , RE Randall , J Ortin and D Jackson (2008). The multifunctional NS1 protein of influenza A viruses. Journal of General Virology 89: 2359–2376.
BM Hause , TA Oleson , RF Bey , DL Stine and RR Simonson (2010). Antigenic categorization of contemporary H3N2 swine influenza virus isolates using a high-throughput serum neutralization assay. Journal of Veterinary Diagnostic Investigation 22: 352–359.
PP Heinen , AP Van Nieuwstadt , EA de Boer-Luijtze and ATJ Bianchi (2001). Analysis of the quality of protection induced by a porcine influenza A vaccine to challenge with an H3N2 virus. Veterinary Immunology and Immunopathology 82: 39–56.
AI Karasin , IH Brown , S Carman and CW Olsen (2000). Isolation and characterization of H4N6 avian influenza viruses from pigs with pneumonia in Canada. Journal of Virology 74: 9322–9327.
H Kida , T Ito , J Yasuda , Y Shimizu , C Itakura , KF Shortridge , Y Kawaoka and RG Webster (1994). Potential for transmission of avian influenza-viruses to pigs. Journal of General Virology 75: 2183–2188.
P Kitikoon , D Nilubol , BJ Erickson , BH Janke , TC Hoover , SA Sornsen and EL Thacker (2006). The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination. Veterinary Immunology and Immunopathology 112: 117–128.
P Kitikoon , AL Vincent , PC Gauger , SN Schlink , DO Bayles , MR Gramer , D Darnell , RJ Webby , KM Lager , SL Swenson and A Klimov (2012). Pathogenicity and transmission in pigs of the novel A(H3N2)v influenza virus isolated from humans and characterization of swine H3N2 viruses isolated in 2010–2011. Journal of Virology 86: 6804–6814.
K Klumpp , RW Ruigrok and F Baudin (1997). Roles of the influenza virus polymerase and nucleoprotein in forming a functional RNP structure. EMBO Journal 16: 1248–1257.
BG Klupp , CJ Hengartner , TC Mettenleiter and LW Enquist (2004). Complete, annotated sequence of the pseudorabies virus genome. Journal of Virology 78: 424–440.
SR Kumar , L Deflube , M Biswas , R Shobana and S Elankumaran (2011). Genetic characterization of swine influenza viruses (H3N2) isolated from Minnesota in 2006–2007. Virus Genes 43: 161–176.
CS Kyriakis , A De Vleeschauwer , F Barbe , M Bublot and K Van Reeth (2009). Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs. Vaccine 27: 2258–2264.
N Landry , BJ Ward , S Trepanier , E Montomoli , M Dargis , G Lapini and LP Vezina (2010). Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. Plos ONE 5: e15559.
DL Larsen and CW Olsen (2002). Effects of DNA dose, route of vaccination, and coadministration of porcine interleukin-6 DNA on results of DNA vaccination against influenza virus infection in pigs. American Journal of Veterinary Research 63: 653–659.
DL Larsen , A Karasin , F Zuckermann and CW Olsen (2000). Systemic and mucosal immune responses to H1N1 influenza virus infection in pigs. Veterinary Microbiology 74: 117–131.
DL Larsen , A Karasin and CW Olsen (2001). Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting. Vaccine 19: 2842–2853.
GX Li , YJ Zhou , H Yu , ZJ Tian , LP Yan , Q Zhang , SP Hu and GZ Tong (2010). Prime-boost immunization with HA/C3d DNA followed by a recombinant pseudorabies virus boost enhanced protective immunity against H3N2 swine influenza virus in mice. Research in Veterinary Science 88: 345–351.
Q Liu , J Ma , H Liu , W Qi , J Anderson , SC Henry , RA Hesse , JA Richt and W Ma (2012). Emergence of novel reassortant H3N2 swine influenza viruses with the 2009 pandemic H1N1 genes in the United States. Archives of Virology 157: 555–562.
A Lorusso , AL Vincent , ML Harland , D Alt , DO Bayles , SL Swenson , MR Gramer , CA Russell , DJ Smith , KM Lager and NS Lewis (2011). Genetic and antigenic characterization of H1 influenza viruses from United States swine from 2008. Journal of General Virology 92: 919–930.
W Ma , AL Vincent , KM Lager , BH Janke , SC Henry , RR Rowland , RA Hesse and JA Richt (2010). Identification and characterization of a highly virulent triple reassortant H1N1 swine influenza virus in the United States. Virus Genes 40: 28–36.
W Ma , SE Belisle , D Mosier , X Li , E Stigger-Rosser , Q Liu , C Qiao , J Elder , R Webby , MG Katze and JA Richt (2011). 2009 pandemic H1N1 influenza virus causes disease and upregulation of genes related to inflammatory and immune responses, cell death, and lipid metabolism in pigs. Journal of Virology 85: 11626–11637.
I Markowska-Daniel , M Pomorska-Mol and Z Pejsak (2011). The influence of age and maternal antibodies on the postvaccinal response against swine influenza viruses in pigs. Veterinary Immunology and Immunopathology 142: 81–86.
A Masic , LA Babiuk and Y Zhou (2009). Reverse genetics-generated elastase-dependent swine influenza viruses are attenuated in pigs. Journal of General Virology 90: 375–385.
A Masic , X Lu , J Li , GK Mutwiri , LA Babiuk , EG Brown and Y Zhou (2010). Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs. Vaccine 28: 7098–7108.
M Matsuda , F Suizu , N Hirata , T Miyazaki , C Obuse and M Noguchi (2010). Characterization of the interaction of influenza virus NS1 with Akt. Biochemical and Biophysical Research Communications 395: 312–317.
A Moreno , L Di Trani , L Alborali , G Vaccari , I Barbieri , E Falcone , E Sozzi , S Puzelli , G Ferri and P Cordioli (2010). First pandemic H1N1 outbreak from a pig farm in Italy. Open Virology Journal 4: 52–56.
MI Nelson , AL Vincent , P Kitikoon , EC Holmes and MR Gramer (2012). Evolution of novel reassortant A/H3N2 influenza viruses in North American swine and humans, 2009–2011. Journal of Virology 86: 8872–8878.
T Nivitchanyong , S Yongkiettrakul , J Kramyu , S Pannengpetch and N Wanasen (2011). Enhanced expression of secretable influenza virus neuraminidase in suspension mammalian cells by influenza virus nonstructural protein 1. Journal of Virological Methods 178: 44–51.
RE O'Neill , J Talon and P Palese (1998). The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO Journal 17: 288–296.
CW Olsen (2000). DNA vaccination against influenza viruses: a review with emphasis on equine and swine influenza. Veterinary Microbiology 74: 149–164.
CW Olsen , AI Karasin , S Carman , Y Li , N Bastien , D Ojkic , D Alves , G Charbonneau , BM Henning , DE Low , L Burton and G Broukhanski (2006). Triple reassortant H3N2 influenza A viruses, Canada, 2005. Emerging Infectious Diseases 12: 1132–1135.
R Paillot , D Hannant , JH Kydd and JM Daly (2006). Vaccination against equine influenza: quid novi? Vaccine 24: 4047–4061.
A Pandey , N Singh , SV Vemula , L Couetil , JM Katz , R Donis , S Sambhara and SK Mittal (2012). Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine. Plos ONE 7: e33428.
TM Pertmer , MD Eisenbraun , D McCabe , SK Prayaga , DH Fuller and JR Haynes (1995). Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 13: 1427–1430.
R Platt , AL Vincent , PC Gauger , CL Loving , EL Zanella , KM Lager , ME Kehrli Jr, K Kimura and JA Roth (2011). Comparison of humoral and cellular immune responses to inactivated swine influenza virus vaccine in weaned pigs. Veterinary Immunology and Immunopathology 142: 252–257.
P Pushko , M Parker , GV Ludwig , NL Davis , RE Johnston and JF Smith (1997). Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology 239: 389–401.
JO Rayner , SA Dryga and KI Kamrud (2002). Alphavirus vectors and vaccination. Reviews in Medical Virology 12: 279–296.
JA Richt , KM Lager , BH Janke , RD Woods , RG Webster and RJ Webby (2003). Pathogenic and antigenic properties of phylogenetically distinct reassortant H3N2 swine influenza viruses cocirculating in the United States. Journal of Clinical Microbiology 41: 3198–3205.
JA Richt , P Lekcharoensuk , KM Lager , AL Vincent , CM Loiacono , BH Janke , WH Wu , KJ Yoon , RJ Webby , A Solorzano and A Garcia-Sastre (2006). Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine. Journal of Virology 80: 11009–11018.
GF Rimmelzwaan and G Sutter (2009). Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara. Expert Review of Vaccines 8: 447–454.
A Romagosa , M Allerson , M Gramer , HS Joo , J Deen , S Detmer and M Torremorell (2011). Vaccination of influenza a virus decreases transmission rates in pigs. Veterinary Research 42: 120.
ML Shaw , KL Stone , CM Colangelo , EE Gulcicek and P Palese (2008). Cellular proteins in influenza virus particles. PLoS Pathogens 4: e1000085.
Y Shoji , JA Chichester , M Jones , SD Manceva , E Damon , V Mett , K Musiychuk , H Bi , C Farrance , M Shamloul , N Kushnir , S Sharma and V Yusibov (2011). Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza. Human Vaccines 7 (Suppl): 41–50.
RE Shope (1931). Swine influenza : III. Filtration experiments and etiology. Journal of Experimental Medicine 54: 373–385.
JJ Skehel and DC Wiley (2000). Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annual Review of Biochemistry 69: 531–569.
A Solorzano , RJ Webby , KM Lager , BH Janke , A Garcia-Sastre and JA Richt (2005). Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs. Journal of Virology 79: 7535–7543.
J Stech , H Garn , M Wegmann , R Wagner and HD Klenk (2005). A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin. Nature Medicine 11: 683–689.
J Talon , M Salvatore , RE O'Neill , Y Nakaya , H Zheng , T Muster , A Garcia-Sastre and P Palese (2000). Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach. Proceedings of the National Academy of Sciences of the United States of America 97: 4309–4314.
EL Thacker , BJ Thacker and BH Janke (2001). Interaction between Mycoplasma hyopneumoniae and swine influenza virus. Journal of Clinical Microbiology 39: 2525–2530.
JM Thompson , MG Nicholson , AC Whitmore , M Zamora , A West , A Iwasaki , HF Staats and RE Johnston (2008). Nonmucosal alphavirus vaccination stimulates a mucosal inductive environment in the peripheral draining lymph node. Journal of Immunology 181: 574–585.
ZJ Tian , GH Zhou , BL Zheng , HJ Qiu , JQ Ni , HL Yang , XN Yin , SP Hu and GZ Tong (2006). A recombinant pseudorabies virus encoding the HA gene from H3N2 subtype swine influenza virus protects mice from virulent challenge. Veterinary Immunology and Immunopathology 111: 211–218.
SX Tong , Y Li , P Rivailler , C Conrardy , DAA Castillo , LM Chen , S Recuenco , JA Ellison , CT Davis , IA York , AS Turmelle , D Moran , S Rogers , M Shi , Y Tao , MR Weil , K Tang , LA Rowe , S Sammons , XY Xu , M Frace , KA Lindblade , NJ Cox , LJ Anderson , CE Rupprecht and RO Donis (2012). A distinct lineage of influenza A virus from bats. Proceedings of the National Academy of Sciences of the United States of America 109: 4269–4274.
D Tremblay , V Allard , JF Doyon , C Bellehumeur , JG Spearman , J Harel and CA Gagnon (2011). Emergence of a new swine H3N2 and pandemic (H1N1) 2009 influenza A virus reassortant in two Canadian animal populations, mink and swine. Journal of Clinical Microbiology 49: 4386–4390.
R Vander Veen , K Kamrud , M Mogler , AT Loynachan , J McVicker , P Berglund , G Owens , S Timberlake , W Lewis , J Smith and DL Harris (2009). Rapid development of an efficacious swine vaccine for novel H1N1. PLoS Currents 1: RRN1123.
RL Vander Veen , AT Loynachan , MA Mogler , BJ Russell , DL Harris and KI Kamrud (2012b). Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine. Vaccine 30: 1944–1950.
K Van Reeth (2000). Cytokines in the pathogenesis of influenza. Veterinary Microbiology 74: 109–116.
C Verheust , M Goossens , K Pauwels and D Breyer (2012). Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination. Vaccine 30: 2623–2632.
AL Vincent , KM Lager , W Ma , P Lekcharoensuk , MR Gramer , C Loiacono and JA Richt (2006). Evaluation of hemagglutinin subtype 1 swine influenza viruses from the United States. Veterinary Microbiology 118: 212–222.
AL Vincent , W Ma , KM Lager , BH Janke , RJ Webby , A Garcia-Sastre and EA Richt (2007). Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine. Vaccine 25: 7999–8009.
AL Vincent , W Ma , KM Lager , BH Janke and JA Richt (2008a). Swine influenza viruses: a North American perspective. Advances in Virus Research 72: 127–154.
AL Vincent , KM Lager , BH Janke , MR Gramer and JA Richt (2008b). Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine. Veterinary Microbiology 126: 310–323.
AL Vincent , W Ma , KM Lager , MR Gramer , JA Richt and BH Janke (2009). Characterization of a newly emerged genetic cluster of H1N1 and H1N2 swine influenza virus in the United States. Virus Genes 39: 176–185.
AL Vincent , JR Ciacci-Zanella , A Lorusso , PC Gauger , EL Zanella , ME Kehrli Jr, BH Janke and KM Lager (2010a). Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs. Vaccine 28: 2782–2787.
AL Vincent , KM Lager , KS Faaberg , M Harland , EL Zanella , JR Ciacci-Zanella , ME Kehrli Jr, BH Janke and A Klimov (2010b). Experimental inoculation of pigs with pandemic H1N1 2009 virus and HI cross-reactivity with contemporary swine influenza virus antisera. Influenza and Other Respiratory Viruses 4: 53–60.
RJ Webby , SL Swenson , SL Krauss , PJ Gerrish , SM Goyal and RG Webster (2000). Evolution of swine H3N2 influenza viruses in the United States. Journal of Virology 74: 8243–8251.
RJ Webby , K Rossow , G Erickson , Y Sims and R Webster (2004). Multiple lineages of antigenically and genetically diverse influenza A virus co-circulate in the United States swine population. Virus Research 103: 67–73.
RG Webster (1999). 1918 Spanish influenza: the secrets remain elusive. Proceedings of the National Academy of Sciences of the United States of America 96: 1164–1166.
RD Wesley and KM Lager (2006). Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus. Veterinary Microbiology 118: 67–75.
RD Wesley , M Tang and KM Lager (2004). Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus. Vaccine 22: 3427–3434.
HM Wise , A Foeglein , JC Sun , RM Dalton , S Patel , W Howard , EC Anderson , WS Barclay and P Digard (2009). A complicated message: identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. Journal of Virology 83: 8021–8031.
JA Wolff , RW Malone , P Williams , W Chong , G Acsadi , A Jani and PL Felgner (1990). Direct gene transfer into mouse muscle in vivo. Science 247: 1465–1468.
Z Yuan , S Zhang , Y Liu , F Zhang , AR Fooks , Q Li and R Hu (2008). A recombinant pseudorabies virus expressing rabies virus glycoprotein: safety and immunogenicity in dogs. Vaccine 26: 1314–1321.
K Zhao , X Shi , Y Zhao , H Wei , Q Sun , T Huang , X Zhang and Y Wang (2011). Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles. Vaccine 29: 8549–8556.